跳至主要内容
临床试验/NCT06031181
NCT06031181招募中3 期

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section: a Single-arm, Multi-center, Phase III Trial

Fudan University1 个研究点 分布在 1 个国家目标入组 390 人开始时间: 2023年3月31日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
390
试验地点
1
主要终点
5-year recurrence-free survival

研究概览

简要总结

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who sign the informed consent form and are willing to complete the study according to the plan;
  • Aged from 18 to 80 years old;
  • ECOG equals 0 or 1;
  • Not receiving lung cancer surgery before;
  • Resectable peripheral cT1N0M0 tumors;
  • Single lung nodules with ground-glass dominant or pure ground-glass on CT, or multiple lung nodules with the major lesion being the aforementioned nodules;
  • Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
  • Not receiving chemotherapy or radiotherapy before.

排除标准

  • Not cT1N0M0;
  • Cannot be completely resected by sublobar resection;
  • Invasive lung adenocarcinoma or not lung adenocarcinoma diagnosed cytologically or pathologically;
  • Receiving lung cancer surgery before;
  • Receiving radiotherapy or chemotherapy.

结局指标

主要结局

5-year recurrence-free survival

时间窗: 5 years

The event is defined as the tumor recurrence.

次要结局

  • 5-year overall survival(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haiquan Chen

Director in the Department of Thoracic Surgery, FUSCC

Fudan University

研究点 (1)

Loading locations...

相似试验